top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
Women's Cancer Research Foundation
May 16, 20222 min read
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
A recent clinical trial revealed that a secondary surgery followed by chemotherapy can improve survival compared to chemotherapy alone.
0 comments
Women's Cancer Research Foundation
Apr 25, 20222 min read
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy. Novel approaches for relapsed ovarian cancer are necessary to improve survival.
0 comments
Women's Cancer Research Foundation
Apr 19, 20221 min read
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
0 comments
Women's Cancer Research Foundation
Mar 28, 20221 min read
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
Women with a BRCA 1 or 2 mutation carriers have an increased risk of developing breast cancer and ovarian cancer. However....
0 comments
Women's Cancer Research Foundation
Mar 22, 20221 min read
A Novel Treatment For Platinum-Resistant Ovarian Cancer
Every year in the U.S., 22,000 to 24,000 women are diagnosed with ovarian cancer. Patient survival depends upon the responses to...
0 comments
Women's Cancer Research Foundation
Mar 16, 20221 min read
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
In a recent study from Gynecologic Oncology, the authors identified ovarian cancer patients who underwent primary surgery from 2004 to 2015.
0 comments
Women's Cancer Research Foundation
Mar 10, 20221 min read
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
In a recent JAMA study, researchers endeavored to determine if there were differences in overall survival among ovarian cancer patients...
0 comments
Women's Cancer Research Foundation
Mar 8, 20222 min read
Why Black Women with Ovarian Cancer Require Greater Focus
While mortality due to ovarian cancer is decreasing overall, Black women continue to have lower survival rates and higher rates of disease..
0 comments
Women's Cancer Research Foundation
Mar 2, 20221 min read
Ovarian Cancer Update
Last year, an estimated 314,000 people worldwide developed ovarian cancer, a condition associated with a 50% mortality rate.
0 comments
Women's Cancer Research Foundation
Feb 9, 20221 min read
Sugary Food and Beverage Consumption and the Risk of Developing Ovarian Cancer
Select researchers have inquired if refined sugars contribute to the manifestation of Ovarian Cancer.
0 comments
Women's Cancer Research Foundation
Nov 5, 20212 min read
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Ovarian cancer is an aggressive disease, with a 10-year survival rate of 35%.
0 comments
Women's Cancer Research Foundation
Nov 3, 20211 min read
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Women who have ever used an intrauterine device (IUD) for birth control may have a 30% lower risk for ovarian cancer.
0 comments
Women's Cancer Research Foundation
Oct 30, 20212 min read
Genital Powder Use and Epithelial Ovarian Cancer
Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.
0 comments
Women's Cancer Research Foundation
Oct 27, 20212 min read
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.
0 comments
Women's Cancer Research Foundation
Oct 22, 20211 min read
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Analyses showed a longer duration of contraceptive use and more recent use were associated with a greater reduction in ovarian cancer risk.
0 comments
Women's Cancer Research Foundation
Oct 14, 20211 min read
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
For the past ten yrs, continued use of bevacizumab therapy in the first-line treatment of ovarian cancer has reportedly improved...
0 comments
Women's Cancer Research Foundation
Sep 20, 20211 min read
Use of Hair Products in Relation to Ovarian Cancer Risk
In 2021 study conducted, the authors evaluated the potential impact of carcinogens from hair products that may be absorbed into bloodstream.
0 comments
Women's Cancer Research Foundation
Sep 3, 20211 min read
Association Between Breastfeeding and Ovarian Cancer Risk
The results from several oncology studies have indicated that breastfeeding is associated with a reduced risk of epithelial ovarian cancer.
0 comments
Women's Cancer Research Foundation
Aug 31, 20212 min read
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Ovarian cancer survivors who had a mental health diagnosis demonstrated an 80% higher risk for mortality.
0 comments
Women's Cancer Research Foundation
Aug 12, 20211 min read
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Oral contraceptive use potentially reduces the risk of breast, ovarian, and endometrial cancers.
0 comments
bottom of page